(Alliance News) - Genus PLC on Tuesday reported good trading as it expects annual adjusted pretax profit to come in higher than the upper end of analyst estimates. Read More
Genus PLC - Basingstoke, England-based animal biotechnology and genetics company - Gets US Food & Drug Administration approval for its 'PRRS resistant pig' gene edit for use in the US food supply chain. PRRS stands for porcine reproductive and respiratory syndrome, a disease that causes suffering and premature death for pigs. Genus says the success with the US FDA follows "years of close collaboration". It now is seeking approvals for the PRP programme in key US export markets, including Canada, Mexico and Japan. It also is making progress with regulators in China and elsewhere. Brazil, Colombia and Dominican Republic already have approved PRP. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday, while overseas data from Eurostat showed the eurozone economy expanding faster than expected. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Genus PLC on Thursday said profit plummeted in the first half of its current financial year, driven by a negative valuation of its assets. Read More
(Alliance News) - European Opportunities Trust PLC on Friday said its net asset value declined, with notable detractors including Novo Nordisk AS and Dassault Systemes SE. Read More
(Alliance News) - Genus PLC reported "encouraging" trading levels on Wednesday ahead of its annual general meeting, though growth has not been consistent across all markets. Read More
Genus PLC - Basingstoke, Hampshire-based animal genetics - Chief Financial Officer Alison Henriksen will retire from Genus to return to Australia at the end of July next year, having been in post for five years. Genus says it has started the search for a successor as CFO. Read More
(Alliance News) - European stocks started the week in fine style buoyed by gains across the pond as investors weigh rate cut hopes ahead of US inflation figures later this week. Read More
Genus PLC - Basingstoke, England-based animal genetics - Chief Executive Jorgen Kokke buys 10,450 shares at average USD23.16, worth USD242,036, on Thursday last week. Chair Iain Ferguson also had purchased shares on Thursday, buying 10,000 shares at 1,763.63 pence to 1,801.00p, worth GBP178,762. Read More
Genus PLC - Basingstoke, England-based animal genetics - Chair Iain Ferguson and wife Catherine buy 10,000 shares at 1,763.63 pence to 1,801.00p, worth GBP178,762, on Thursday. Read More
